{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,21]],"date-time":"2026-03-21T23:45:51Z","timestamp":1774136751388,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T00:00:00Z","timestamp":1580947200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Vascular diseases are commonly observed in patients with autosomal dominant polycystic kidney disease (ADPKD). We aim to investigate the differences in the risk for arteriovenous fistula or graft (AVF\/AVG) dysfunction in haemodialysis (HD) patients with and without ADPKD. 557 ADPKD and 1671 non-ADPKD patients were enrolled in the study after propensity score matching. The primary outcome measure is the incidence rate of AVF\/AVG dysfunction. The incidence rates and risks of AVF\/AVG dysfunction (per 100 person-years) for ADPKD and non-ADPKD patients were (1) 38.83 and 48.99 [SHR\u2009=\u20090.79, P\u2009=\u20090.137], respectively, for within 90 days, (2) 45.85 and 51.31 [SHR\u2009=\u20090.90, P\u2009=\u20090.300], respectively, for within 180 days, (3) 44.42 and 41.40 [SHR\u2009=\u20091.08, P\u2009=\u20090.361], respectively, for within the first year, (4) 27.38 and 24.69 [SHR\u2009=\u20091.09, P\u2009=\u20090.168], respectively, for within 5 years, (5) 17.35 and 13.80 [SHR\u2009=\u20091.19, P\u2009=\u20090.045], respectively, for between the 1st and 10th year, and (6) 25.40 and 21.22 [SHR\u2009=\u20091.14, P\u2009=\u20090.031], respectively, for all periods. ADPKD patients had lower incidence rates of AVF\/AVG dysfunction within the first 180 days than non-ADPKD patients, but presented a higher incidence rate after 1 year of AVF\/AVG creation and onwards.<\/jats:p>","DOI":"10.1038\/s41598-020-58441-5","type":"journal-article","created":{"date-parts":[[2020,2,6]],"date-time":"2020-02-06T11:04:48Z","timestamp":1580987088000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prognosis of Vascular Access in Haemodialysis Patients with Autosomal Dominant Polycystic Kidney Disease"],"prefix":"10.1038","volume":"10","author":[{"given":"Tsung-Lun","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun-Fan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann Charis","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chia-Hao","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuo-Ming","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan-Yu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ko-Wen","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yung-Tai","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Ching","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,2,6]]},"reference":[{"key":"58441_CR1","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1038\/ki.2015.59","volume":"88","author":"AB Chapman","year":"2015","unstructured":"Chapman, A. B. et al. Autosomal-dominant polycystic kidney disease (ADPKD): executive summary from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney Int. 88, 17\u201327, https:\/\/doi.org\/10.1038\/ki.2015.59 (2015).","journal-title":"Kidney Int."},{"key":"58441_CR2","doi-asserted-by":"publisher","first-page":"755","DOI":"10.5301\/jn.5000224","volume":"26","author":"PW Lee","year":"2013","unstructured":"Lee, P. W., Chien, C. C., Yang, W. C., Wang, J. J. & Lin, C. C. Epidemiology and mortality in dialysis patients with and without polycystic kidney disease: a national study in Taiwan. J. Nephrol. 26, 755\u2013762, https:\/\/doi.org\/10.5301\/jn.5000224 (2013).","journal-title":"J. Nephrol."},{"key":"58441_CR3","doi-asserted-by":"publisher","first-page":"e2166","DOI":"10.1097\/MD.0000000000002166","volume":"94","author":"JY Yang","year":"2015","unstructured":"Yang, J. Y. et al. Outcome Comparisons Between Patients on Peritoneal Dialysis With and Without Polycystic Kidney Disease: A Nationwide Matched Cohort Study. Med. 94, e2166, https:\/\/doi.org\/10.1097\/MD.0000000000002166 (2015).","journal-title":"Med."},{"key":"58441_CR4","doi-asserted-by":"publisher","DOI":"10.1038\/srep12816","volume":"5","author":"JY Yang","year":"2015","unstructured":"Yang, J. Y. et al. Comparative Study of Outcomes among Patients with Polycystic Kidney Disease on Hemodialysis and Peritoneal Dialysis. Sci. Rep. 5, 12816, https:\/\/doi.org\/10.1038\/srep12816 (2015).","journal-title":"Sci. Rep."},{"key":"58441_CR5","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1681\/ASN.V7112483","volume":"7","author":"R Torra","year":"1996","unstructured":"Torra, R. et al. Abdominal aortic aneurysms and autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 7, 2483\u20132486 (1996).","journal-title":"J. Am. Soc. Nephrol."},{"key":"58441_CR6","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1093\/ndt\/17.5.819","volume":"17","author":"S Graf","year":"2002","unstructured":"Graf, S. et al. Intracranial aneurysms and dolichoectasia in autosomal dominant polycystic kidney disease. Nephrol. Dial. Transpl. 17, 819\u2013823 (2002).","journal-title":"Nephrol. Dial. Transpl."},{"key":"58441_CR7","doi-asserted-by":"publisher","first-page":"916","DOI":"10.1056\/NEJM199209243271303","volume":"327","author":"AB Chapman","year":"1992","unstructured":"Chapman, A. B. et al. Intracranial aneurysms in autosomal dominant polycystic kidney disease. N. Engl. J. Med. 327, 916\u2013920, https:\/\/doi.org\/10.1056\/NEJM199209243271303 (1992).","journal-title":"N. Engl. J. Med."},{"key":"58441_CR8","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1148\/radiology.191.1.8134594","volume":"191","author":"PM Ruggieri","year":"1994","unstructured":"Ruggieri, P. M. et al. Occult intracranial aneurysms in polycystic kidney disease: screening with MR angiography. Radiology 191, 33\u201339, https:\/\/doi.org\/10.1148\/radiology.191.1.8134594 (1994).","journal-title":"Radiology"},{"key":"58441_CR9","doi-asserted-by":"publisher","first-page":"1875","DOI":"10.1093\/hmg\/ddg190","volume":"12","author":"Q Qian","year":"2003","unstructured":"Qian, Q. et al. Pkd2 haploinsufficiency alters intracellular calcium regulation in vascular smooth muscle cells. Hum. Mol. Genet. 12, 1875\u20131880 (2003).","journal-title":"Hum. Mol. Genet."},{"key":"58441_CR10","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.2215\/CJN.09441209","volume":"5","author":"M Monroy-Cuadros","year":"2010","unstructured":"Monroy-Cuadros, M., Yilmaz, S., Salazar-Banuelos, A. & Doig, C. Risk factors associated with patency loss of hemodialysis vascular access within 6 months. Clin. J. Am. Soc. Nephrol. 5, 1787\u20131792, https:\/\/doi.org\/10.2215\/CJN.09441209 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"58441_CR11","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1093\/ndt\/14.7.1651","volume":"14","author":"JA Rodriguez","year":"1999","unstructured":"Rodriguez, J. A., Lopez, J., Cleries, M. & Vela, E. Vascular access for haemodialysis\u2013an epidemiological study of the Catalan Renal Registry. Nephrol. Dial. Transpl. 14, 1651\u20131657 (1999).","journal-title":"Nephrol. Dial. Transpl."},{"key":"58441_CR12","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000045984","volume":"88","author":"A Kato","year":"2001","unstructured":"Kato, A., Takita, T., Furuhashi, M., Maruyama, Y. & Hishida, A. Abdominal aortic aneurysms in hemodialysis patients with autosomal dominant polycystic kidney disease. Nephron 88, 185\u2013186, https:\/\/doi.org\/10.1159\/000045984 (2001).","journal-title":"Nephron"},{"key":"58441_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/bf02014921","volume":"3","author":"M Palestini","year":"1994","unstructured":"Palestini, M. et al. Abdominal aortic aneurysm in patients submitted to chronic hemodialysis for autosomal dominant polycystic kidney disease: Personal experience. International. J. Angiology 3, 90\u201392, https:\/\/doi.org\/10.1007\/bf02014921 (1994).","journal-title":"J. Angiology"},{"key":"58441_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1038\/ng0695-151","volume":"10","author":"J Hughes","year":"1995","unstructured":"Hughes, J. et al. The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat. Genet. 10, 151\u2013160, https:\/\/doi.org\/10.1038\/ng0695-151 (1995).","journal-title":"Nat. Genet."},{"key":"58441_CR15","doi-asserted-by":"publisher","first-page":"28557","DOI":"10.1074\/jbc.274.40.28557","volume":"274","author":"Y Cai","year":"1999","unstructured":"Cai, Y. et al. Identification and characterization of polycystin-2, the PKD2 gene product. J. Biol. Chem. 274, 28557\u201328565 (1999).","journal-title":"J. Biol. Chem."},{"key":"58441_CR16","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1006\/bbrc.2001.4554","volume":"282","author":"PM Vassilev","year":"2001","unstructured":"Vassilev, P. M. et al. Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. Biochem. Biophys. Res. Commun. 282, 341\u2013350, https:\/\/doi.org\/10.1006\/bbrc.2001.4554 (2001).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"58441_CR17","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/ncb754","volume":"4","author":"P Koulen","year":"2002","unstructured":"Koulen, P. et al. Polycystin-2 is an intracellular calcium release channel. Nat. Cell Biol. 4, 191\u2013197, https:\/\/doi.org\/10.1038\/ncb754 (2002).","journal-title":"Nat. Cell Biol."},{"key":"58441_CR18","doi-asserted-by":"publisher","first-page":"2196","DOI":"10.1016\/s0140-6736(03)13773-7","volume":"361","author":"S Rossetti","year":"2003","unstructured":"Rossetti, S. et al. Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet 361, 2196\u20132201, https:\/\/doi.org\/10.1016\/s0140-6736(03)13773-7 (2003).","journal-title":"Lancet"},{"key":"58441_CR19","doi-asserted-by":"publisher","first-page":"1731","DOI":"10.1073\/pnas.040550097","volume":"97","author":"K Kim","year":"2000","unstructured":"Kim, K., Drummond, I., Ibraghimov-Beskrovnaya, O., Klinger, K. & Arnaout, M. A. Polycystin 1 is required for the structural integrity of blood vessels. Proc. Natl Acad. Sci. USA 97, 1731\u20131736 (2000).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"58441_CR20","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1053\/j.ajkd.2004.01.011","volume":"43","author":"O Kocaman","year":"2004","unstructured":"Kocaman, O. et al. Endothelial dysfunction and increased carotid intima-media thickness in patients with autosomal dominant polycystic kidney disease. Am. J. Kidney Dis. 43, 854\u2013860 (2004).","journal-title":"Am. J. Kidney Dis."},{"key":"58441_CR21","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1159\/000101369","volume":"27","author":"ML Borresen","year":"2007","unstructured":"Borresen, M. L., Wang, D. & Strandgaard, S. Pulse wave reflection is amplified in normotensive patients with autosomal-dominant polycystic kidney disease and normal renal function. Am. J. Nephrol. 27, 240\u2013246, https:\/\/doi.org\/10.1159\/000101369 (2007).","journal-title":"Am. J. Nephrol."},{"key":"58441_CR22","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.2215\/cjn.05850518","volume":"13","author":"KL Nowak","year":"2018","unstructured":"Nowak, K. L. et al. Vascular Dysfunction, Oxidative Stress, and Inflammation in Autosomal Dominant Polycystic Kidney Disease. Clin. J. Am. Soc. Nephrol. 13, 1493\u20131501, https:\/\/doi.org\/10.2215\/cjn.05850518 (2018).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"58441_CR23","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1681\/asn.2008080882","volume":"20","author":"RW Schrier","year":"2009","unstructured":"Schrier, R. W. Renal volume, renin-angiotensin-aldosterone system, hypertension, and left ventricular hypertrophy in patients with autosomal dominant polycystic kidney disease. J. Am. Soc. Nephrol. 20, 1888\u20131893, https:\/\/doi.org\/10.1681\/asn.2008080882 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"58441_CR24","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00701-017-3142-z","volume":"159","author":"F Cagnazzo","year":"2017","unstructured":"Cagnazzo, F., Gambacciani, C., Morganti, R. & Perrini, P. Intracranial aneurysms in patients with autosomal dominant polycystic kidney disease: prevalence, risk of rupture, and management. A systematic review. Acta Neurochir. 159, 811\u2013821, https:\/\/doi.org\/10.1007\/s00701-017-3142-z (2017).","journal-title":"Acta Neurochir."},{"key":"58441_CR25","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1159\/000368475","volume":"39","author":"M Niemczyk","year":"2014","unstructured":"Niemczyk, M. et al. Blood Pressure and Intracranial Aneurysms in Autosomal Dominant Polycystic Kidney Disease. Kidney Blood Press. Res. 39, 630\u2013635 (2014).","journal-title":"Kidney Blood Press. Res."},{"key":"58441_CR26","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1053\/j.ajkd.2010.08.010","volume":"56","author":"DA Goodkin","year":"2010","unstructured":"Goodkin, D. A. et al. Hemodialysis Vascular Access Training and Practices Are Key to Improved Access Outcomes. Am. J. Kidney Dis. 56, 1032\u20131042 (2010).","journal-title":"Am. J. Kidney Dis."},{"key":"58441_CR27","doi-asserted-by":"publisher","first-page":"e0166362","DOI":"10.1371\/journal.pone.0166362","volume":"11","author":"FA Chen","year":"2016","unstructured":"Chen, F. A. et al. Angiotensin converting-enzyme inhibitors, angiotensin receptor blockers, and calcium channel blockers are associated with prolonged vascular access patency in uremic patients undergoing hemodialysis. PLoS one 11, e0166362, https:\/\/doi.org\/10.1371\/journal.pone.0166362 (2016).","journal-title":"PLoS one"},{"key":"58441_CR28","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1111\/hdi.12165","volume":"18","author":"HS Chen","year":"2014","unstructured":"Chen, H. S., Cheng, C. T., Hou, C. C. & Liou, H. H. Survival and other clinical outcomes of maintenance hemodialysis patients in Taiwan: A 5-year multicenter follow-up study. Hemodial. Int. 18, 799\u2013808, https:\/\/doi.org\/10.1111\/hdi.12165 (2014).","journal-title":"Hemodial. Int."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58441-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58441-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,2]],"date-time":"2023-01-02T14:48:22Z","timestamp":1672670902000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-020-58441-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,6]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["58441"],"URL":"https:\/\/doi.org\/10.1038\/s41598-020-58441-5","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,6]]},"assertion":[{"value":"17 June 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 January 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1985"}}